Co-Authors
This is a "connection" page, showing publications co-authored by Benjamin tenOever and Daisy Hoagland.
Connection Strength
1.157
-
Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity. 2021 03 09; 54(3):557-570.e5.
Score: 0.927
-
Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. Sci Rep. 2021 06 25; 11(1):13308.
Score: 0.060
-
Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection. Stem Cell Reports. 2021 03 09; 16(3):505-518.
Score: 0.058
-
Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells. Cell. 2021 01 07; 184(1):92-105.e16.
Score: 0.057
-
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. Cell Stem Cell. 2020 07 02; 27(1):125-136.e7.
Score: 0.055